Medical - Care Facilities
Compare Stocks
4 / 10Stock Comparison
CCM vs AMSF vs RDNT vs KNTK
Revenue, margins, valuation, and 5-year total return — side by side.
Insurance - Specialty
Medical - Diagnostics & Research
Oil & Gas Midstream
CCM vs AMSF vs RDNT vs KNTK — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | ||||
|---|---|---|---|---|
| Industry | Medical - Care Facilities | Insurance - Specialty | Medical - Diagnostics & Research | Oil & Gas Midstream |
| Market Cap | $748K | $569M | $4.45B | $3.33B |
| Revenue (TTM) | $366M | $325M | $2.04B | $1.73B |
| Net Income (TTM) | $-163M | $46M | $47M | $228M |
| Gross Margin | -11.4% | 47.6% | 11.2% | 24.8% |
| Operating Margin | -131.0% | 17.8% | 3.0% | 8.2% |
| Forward P/E | 1.2x | 14.4x | 91.8x | 42.4x |
| Total Debt | $3.93B | $491K | $1.86B | $3.87B |
| Cash & Equiv. | $216M | $62M | $767M | $4M |
CCM vs AMSF vs RDNT vs KNTK — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| Concord Medical Ser… (CCM) | 100 | 37.0 | -63.0% |
| AMERISAFE, Inc. (AMSF) | 100 | 49.4 | -50.6% |
| RadNet, Inc. (RDNT) | 100 | 337.4 | +237.4% |
| Kinetik Holdings In… (KNTK) | 100 | 702.3 | +602.3% |
Price return only. Dividends and distributions are not included.
Quick Verdict: CCM vs AMSF vs RDNT vs KNTK
Each card shows where this stock fits in a portfolio — not just who wins on paper.
CCM is the clearest fit if your priority is value.
- Lower P/E (1.2x vs 91.8x)
AMSF carries the broadest edge in this set and is the clearest fit for sleep-well-at-night.
- Lower volatility, beta 0.23, Low D/E 0.2%, current ratio 0.32x
- 14.3% margin vs CCM's -44.6%
- Beta 0.23 vs RDNT's 1.43, lower leverage
- 5.6% ROA vs CCM's -2.4%, ROIC 21.9% vs -7.7%
RDNT is the clearest fit if your priority is long-term compounding.
- 9.5% 10Y total return vs AMSF's 31.8%
KNTK is the #2 pick in this set and the best alternative if income & stability and growth exposure is your priority.
- Dividend streak 3 yrs, beta 0.60, yield 16.5%
- Rev growth 19.0%, EPS growth 157.8%, 3Y rev CAGR 13.3%
- Beta 0.60, yield 16.5%, current ratio 0.69x
- 19.0% revenue growth vs CCM's -28.6%
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 19.0% revenue growth vs CCM's -28.6% | |
| Value | Lower P/E (1.2x vs 91.8x) | |
| Quality / Margins | 14.3% margin vs CCM's -44.6% | |
| Stability / Safety | Beta 0.23 vs RDNT's 1.43, lower leverage | |
| Dividends | 16.5% yield, 3-year raise streak, vs AMSF's 8.4%, (2 stocks pay no dividend) | |
| Momentum (1Y) | +28.0% vs AMSF's -29.2% | |
| Efficiency (ROA) | 5.6% ROA vs CCM's -2.4%, ROIC 21.9% vs -7.7% |
CCM vs AMSF vs RDNT vs KNTK — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
Segment breakdown not available.
CCM vs AMSF vs RDNT vs KNTK — Financial Metrics
Side-by-side numbers across 4 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
AMSF leads in 2 of 6 categories
CCM leads 1 • RDNT leads 1 • KNTK leads 1 • 1 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
AMSF leads this category, winning 3 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
RDNT is the larger business by revenue, generating $2.0B annually — 6.3x AMSF's $325M. AMSF is the more profitable business, keeping 14.3% of every revenue dollar as net income compared to CCM's -44.6%. On growth, RDNT holds the edge at +14.8% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | ||||
|---|---|---|---|---|
| RevenueTrailing 12 months | $366M | $325M | $2.0B | $1.7B |
| EBITDAEarnings before interest/tax | -$359M | $58M | $214M | $534M |
| Net IncomeAfter-tax profit | -$163M | $46M | $47M | $228M |
| Free Cash FlowCash after capex | $0 | $8M | -$178M | $441M |
| Gross MarginGross profit ÷ Revenue | -11.4% | +47.6% | +11.2% | +24.8% |
| Operating MarginEBIT ÷ Revenue | -131.0% | +17.8% | +3.0% | +8.2% |
| Net MarginNet income ÷ Revenue | -44.6% | +14.3% | +2.3% | +13.2% |
| FCF MarginFCF ÷ Revenue | -2.1% | +2.5% | -8.7% | +25.5% |
| Rev. Growth (YoY)Latest quarter vs prior year | -8.3% | +10.3% | +14.8% | -7.5% |
| EPS Growth (YoY)Latest quarter vs prior year | +84.0% | -8.5% | -114.1% | -2.4% |
Valuation Metrics
CCM leads this category, winning 3 of 6 comparable metrics.
Valuation Metrics
At 12.3x trailing earnings, AMSF trades at a 33% valuation discount to KNTK's 18.4x P/E. On an enterprise value basis, AMSF's 8.5x EV/EBITDA is more attractive than RDNT's 25.9x.
| Metric | ||||
|---|---|---|---|---|
| Market CapShares × price | $748,461 | $569M | $4.5B | $3.3B |
| Enterprise ValueMkt cap + debt − cash | $547M | $508M | $5.5B | $7.2B |
| Trailing P/EPrice ÷ TTM EPS | -0.02x | 12.27x | -230.00x | 18.43x |
| Forward P/EPrice ÷ next-FY EPS est. | 1.23x | 14.42x | 91.75x | 42.44x |
| PEG RatioP/E ÷ EPS growth rate | — | — | — | — |
| EV / EBITDAEnterprise value multiple | — | 8.53x | 25.88x | 13.14x |
| Price / SalesMarket cap ÷ Revenue | 0.01x | 1.80x | 2.18x | 1.89x |
| Price / BookPrice ÷ Book value/share | 0.00x | 2.30x | 3.19x | 1.04x |
| Price / FCFMarket cap ÷ FCF | — | 63.83x | 52.01x | 44.78x |
Profitability & Efficiency
AMSF leads this category, winning 7 of 9 comparable metrics.
Profitability & Efficiency
KNTK delivers a 21.1% return on equity — every $100 of shareholder capital generates $21 in annual profit, vs $-10 for CCM. AMSF carries lower financial leverage with a 0.00x debt-to-equity ratio, signaling a more conservative balance sheet compared to CCM's 2.43x. On the Piotroski fundamental quality scale (0–9), AMSF scores 7/9 vs CCM's 3/9, reflecting strong financial health.
| Metric | ||||
|---|---|---|---|---|
| ROE (TTM)Return on equity | -9.8% | +9.7% | +3.8% | +21.1% |
| ROA (TTM)Return on assets | -2.4% | +5.6% | +1.3% | +4.2% |
| ROICReturn on invested capital | -7.7% | +21.9% | +2.0% | +1.9% |
| ROCEReturn on capital employed | -12.2% | +16.8% | +2.1% | +2.5% |
| Piotroski ScoreFundamental quality 0–9 | 3 | 7 | 5 | 4 |
| Debt / EquityFinancial leverage | 2.43x | 0.00x | 1.37x | 1.32x |
| Net DebtTotal debt minus cash | $3.7B | -$61M | $1.1B | $3.9B |
| Cash & Equiv.Liquid assets | $216M | $62M | $767M | $4M |
| Total DebtShort + long-term debt | $3.9B | $491,000 | $1.9B | $3.9B |
| Interest CoverageEBIT ÷ Interest expense | -2.40x | — | 1.46x | 5.98x |
Total Returns (Dividends Reinvested)
RDNT leads this category, winning 4 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in RDNT five years ago would be worth $24,710 today (with dividends reinvested), compared to $1,512 for CCM. Over the past 12 months, KNTK leads with a +28.0% total return vs AMSF's -29.2%. The 3-year compound annual growth rate (CAGR) favors RDNT at 26.0% vs CCM's -27.2% — a key indicator of consistent wealth creation.
| Metric | ||||
|---|---|---|---|---|
| YTD ReturnYear-to-date | +20.4% | -18.3% | -19.0% | +37.4% |
| 1-Year ReturnPast 12 months | -28.4% | -29.2% | +4.6% | +28.0% |
| 3-Year ReturnCumulative with dividends | -61.4% | -24.8% | +100.0% | +93.9% |
| 5-Year ReturnCumulative with dividends | -84.9% | -18.9% | +147.1% | +93.1% |
| 10-Year ReturnCumulative with dividends | -88.8% | +31.8% | +947.4% | -33.5% |
| CAGR (3Y)Annualised 3-year return | -27.2% | -9.1% | +26.0% | +24.7% |
Risk & Volatility
Evenly matched — AMSF and KNTK each lead in 1 of 2 comparable metrics.
Risk & Volatility
AMSF is the less volatile stock with a 0.23 beta — it tends to amplify market swings less than RDNT's 1.43 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. KNTK currently trades 94.8% from its 52-week high vs CCM's 47.7% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | ||||
|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 0.53x | 0.23x | 1.43x | 0.60x |
| 52-Week HighHighest price in past year | $10.77 | $48.54 | $85.84 | $51.11 |
| 52-Week LowLowest price in past year | $3.18 | $29.42 | $50.76 | $31.33 |
| % of 52W HighCurrent price vs 52-week peak | +47.7% | +62.4% | +67.0% | +94.8% |
| RSI (14)Momentum oscillator 0–100 | 67.5 | 34.2 | 51.3 | 51.3 |
| Avg Volume (50D)Average daily shares traded | 11K | 212K | 822K | 1.2M |
Analyst Outlook
KNTK leads this category, winning 2 of 2 comparable metrics.
Analyst Outlook
Analyst consensus: CCM as "Buy", AMSF as "Buy", RDNT as "Buy", KNTK as "Buy". Consensus price targets imply 60.0% upside for RDNT (target: $92) vs -1.8% for KNTK (target: $48). For income investors, KNTK offers the higher dividend yield at 16.47% vs AMSF's 8.41%.
| Metric | ||||
|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Buy | Buy | Buy | Buy |
| Price TargetConsensus 12-month target | — | $44.50 | $92.00 | $47.57 |
| # AnalystsCovering analysts | 2 | 6 | 11 | 15 |
| Dividend YieldAnnual dividend ÷ price | — | +8.4% | — | +16.5% |
| Dividend StreakConsecutive years of raises | 0 | 0 | 0 | 3 |
| Dividend / ShareAnnual DPS | — | $2.55 | — | $7.98 |
| Buyback YieldShare repurchases ÷ mkt cap | 0.0% | +2.1% | 0.0% | +5.3% |
AMSF leads in 2 of 6 categories (Income & Cash Flow, Profitability & Efficiency). CCM leads in 1 (Valuation Metrics). 1 tied.
CCM vs AMSF vs RDNT vs KNTK: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is CCM or AMSF or RDNT or KNTK a better buy right now?
For growth investors, Kinetik Holdings Inc.
(KNTK) is the stronger pick with 19. 0% revenue growth year-over-year, versus -28. 6% for Concord Medical Services Holdings Limited (CCM). AMERISAFE, Inc. (AMSF) offers the better valuation at 12. 3x trailing P/E (14. 4x forward), making it the more compelling value choice. Analysts rate Concord Medical Services Holdings Limited (CCM) a "Buy" — based on 2 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — CCM or AMSF or RDNT or KNTK?
On trailing P/E, AMERISAFE, Inc.
(AMSF) is the cheapest at 12. 3x versus Kinetik Holdings Inc. at 18. 4x. On forward P/E, Concord Medical Services Holdings Limited is actually cheaper at 1. 2x — notably different from the trailing picture, reflecting expected earnings growth.
03Which is the better long-term investment — CCM or AMSF or RDNT or KNTK?
Over the past 5 years, RadNet, Inc.
(RDNT) delivered a total return of +147. 1%, compared to -84. 9% for Concord Medical Services Holdings Limited (CCM). Over 10 years, the gap is even starker: RDNT returned +947. 4% versus CCM's -88. 8%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — CCM or AMSF or RDNT or KNTK?
By beta (market sensitivity over 5 years), AMERISAFE, Inc.
(AMSF) is the lower-risk stock at 0. 23β versus RadNet, Inc. 's 1. 43β — meaning RDNT is approximately 517% more volatile than AMSF relative to the S&P 500. On balance sheet safety, AMERISAFE, Inc. (AMSF) carries a lower debt/equity ratio of 0% versus 2% for Concord Medical Services Holdings Limited — giving it more financial flexibility in a downturn.
05Which is growing faster — CCM or AMSF or RDNT or KNTK?
By revenue growth (latest reported year), Kinetik Holdings Inc.
(KNTK) is pulling ahead at 19. 0% versus -28. 6% for Concord Medical Services Holdings Limited (CCM). On earnings-per-share growth, the picture is similar: Kinetik Holdings Inc. grew EPS 157. 8% year-over-year, compared to -768. 4% for RadNet, Inc.. Over a 3-year CAGR, KNTK leads at 13. 3% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — CCM or AMSF or RDNT or KNTK?
AMERISAFE, Inc.
(AMSF) is the more profitable company, earning 14. 9% net margin versus -80. 3% for Concord Medical Services Holdings Limited — meaning it keeps 14. 9% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: AMSF leads at 18. 6% versus -138. 6% for CCM. At the gross margin level — before operating expenses — AMSF leads at 46. 4%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is CCM or AMSF or RDNT or KNTK more undervalued right now?
On forward earnings alone, Concord Medical Services Holdings Limited (CCM) trades at 1.
2x forward P/E versus 91. 8x for RadNet, Inc. — 90. 5x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for RDNT: 60. 0% to $92. 00.
08Which pays a better dividend — CCM or AMSF or RDNT or KNTK?
In this comparison, KNTK (16.
5% yield), AMSF (8. 4% yield) pay a dividend. CCM, RDNT do not pay a meaningful dividend and should not be held primarily for income.
09Is CCM or AMSF or RDNT or KNTK better for a retirement portfolio?
For long-horizon retirement investors, AMERISAFE, Inc.
(AMSF) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 23), 8. 4% yield). Both have compounded well over 10 years (AMSF: +31. 8%, RDNT: +947. 4%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between CCM and AMSF and RDNT and KNTK?
These companies operate in different sectors (CCM (Healthcare) and AMSF (Financial Services) and RDNT (Healthcare) and KNTK (Energy)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.
In terms of investment character: CCM is a small-cap quality compounder stock; AMSF is a small-cap deep-value stock; RDNT is a small-cap quality compounder stock; KNTK is a small-cap high-growth stock. AMSF, KNTK pay a dividend while CCM, RDNT do not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.